ACADIA Cash And Short Term Investments from 2010 to 2024
ACAD Stock | USD 14.79 0.06 0.40% |
Cash And Short Term Investments | First Reported 2003-12-31 | Previous Quarter 438.9 M | Current Value 470.5 M | Quarterly Volatility 209.4 M |
Check ACADIA Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ACADIA main balance sheet or income statement drivers, such as Interest Expense of 8 M, Selling General Administrative of 412.7 M or Total Revenue of 762.8 M, as well as many exotic indicators such as Price To Sales Ratio of 6.71, Dividend Yield of 0.0 or PTB Ratio of 12.47. ACADIA financial statements analysis is a perfect complement when working with ACADIA Pharmaceuticals Valuation or Volatility modules.
ACADIA | Cash And Short Term Investments |
Latest ACADIA Pharmaceuticals' Cash And Short Term Investments Growth Pattern
Below is the plot of the Cash And Short Term Investments of ACADIA Pharmaceuticals over the last few years. Short Term Investments is an account in the current assets section of ACADIA Pharmaceuticals balance sheet. This account contains ACADIA Pharmaceuticals investments that will expire within one year. These investments include stocks and bonds that can be liquidated by ACADIA Pharmaceuticals fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. ACADIA Pharmaceuticals' Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ACADIA Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Cash And Short Term Investments | 10 Years Trend |
|
Cash And Short Term Investments |
Timeline |
ACADIA Cash And Short Term Investments Regression Statistics
Arithmetic Mean | 346,252,835 | |
Geometric Mean | 240,458,053 | |
Coefficient Of Variation | 60.56 | |
Mean Deviation | 171,275,620 | |
Median | 341,342,000 | |
Standard Deviation | 209,689,362 | |
Sample Variance | 43969.6T | |
Range | 685M | |
R-Value | 0.68 | |
Mean Square Error | 25266.9T | |
R-Squared | 0.47 | |
Significance | 0.01 | |
Slope | 32,021,518 | |
Total Sum of Squares | 615574.8T |
ACADIA Cash And Short Term Investments History
About ACADIA Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include ACADIA Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. ACADIA Pharmaceuticals investors use historical funamental indicators, such as ACADIA Pharmaceuticals's Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although ACADIA Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in ACADIA Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ACADIA Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ACADIA Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ACADIA Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Cash And Short Term Investments | 438.9 M | 269.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.C | Citigroup | |
CRM | Salesforce | |
MSFT | Microsoft |
Check out the analysis of ACADIA Pharmaceuticals Correlation against competitors. For information on how to trade ACADIA Stock refer to our How to Trade ACADIA Stock guide.Note that the ACADIA Pharmaceuticals information on this page should be used as a complementary analysis to other ACADIA Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for ACADIA Stock analysis
When running ACADIA Pharmaceuticals' price analysis, check to measure ACADIA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACADIA Pharmaceuticals is operating at the current time. Most of ACADIA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ACADIA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ACADIA Pharmaceuticals' price. Additionally, you may evaluate how the addition of ACADIA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |
Is ACADIA Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ACADIA Pharmaceuticals. If investors know ACADIA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ACADIA Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 4.949 | Quarterly Revenue Growth 0.738 | Return On Assets (0) | Return On Equity (0) |
The market value of ACADIA Pharmaceuticals is measured differently than its book value, which is the value of ACADIA that is recorded on the company's balance sheet. Investors also form their own opinion of ACADIA Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is ACADIA Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACADIA Pharmaceuticals' market value can be influenced by many factors that don't directly affect ACADIA Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACADIA Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if ACADIA Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACADIA Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.